Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Long-Term Debt Repayments (2023 - 2025)

Spruce Biosciences (SPRB) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $841000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 107.14% to $841000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 26.82% increase, with the full-year FY2025 number at $2.1 million, up 26.82% from a year prior.
  • Long-Term Debt Repayments was $841000.0 for Q4 2025 at Spruce Biosciences, up from $405000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $841000.0 in Q4 2025 to a low of $405000.0 in Q1 2023.
  • A 3-year average of $441750.0 and a median of $405500.0 in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: changed 0.0% in 2024, then surged 107.14% in 2025.
  • Spruce Biosciences' Long-Term Debt Repayments stood at $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then skyrocketed by 107.14% to $841000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Long-Term Debt Repayments are $841000.0 (Q4 2025), $405000.0 (Q3 2025), and $406000.0 (Q2 2025).